Abstract:The signal sequences of the human cytomegalovirus (CMV) UL40 protein and its rhesus CMV (RhCMV) counterpart, Rh67, contain a peptide (VMAPRT[L/V][F/I/L/V]L, VL9) that is presented by major histocompatibility complex (MHC) antigen E (MHC-E). The CMV VL9 peptides replace VL9 peptides derived from classical MHC (Ia) signal sequences, which are lost when CMV disrupts antigen processing and presentation and MHC Ia expression. This allows infected cells to maintain MHC-E surface expression and escape killing by Natural Killer cells. We demonstrate that processing of the Rh67 VL9 peptide mirrors that of UL40, despite the lack of sequence conservation between the two proteins. Processing of both VL9 peptides is dependent on cleavage of their signal sequences by the host protease signal peptide peptidase. As previously shown for UL40, up-regulation of MHC-E expression by Rh67 requires only its signal sequence, with sequences upstream of VL9 critical for conferring independence from TAP, the transporter associated with antigen processing. Our results also suggest that the mature UL40 and Rh67 proteins contribute to CMV immune evasion by decreasing surface expression of MHC Ia. Unexpectedly, while the Rh67 VL9 peptide is resistant to the effects of Rh67, UL40 can partially counteract the up-regulation of MHC-E expression mediated by its own VL9 peptide. This suggests differences in the mechanisms by which the two VL9 peptides up-regulate MHC-E, and further work will be required to determine if any such differences have implications for translating a RhCMV-vectored simian immunodeficiency virus (SIV) vaccine to HIV-1 using human CMV as a vector. Importance: The protective immune response induced by a rhesus cytomegalovirus (RhCMV)-vectored simian immunodeficiency virus (SIV) vaccine in rhesus macaques depends on the presence of the viral Rh67 gene in the vaccine. The Rh67 protein contains a peptide that allows the RhCMV-infected cells to maintain expression of major histocompatibility complex (MHC) antigen E at the cell surface. We show that production of this peptide, referred to as "VL9," mirrors that of the equivalent peptide present in the human cytomegalovirus (CMV) protein UL40, despite the little sequence similarity between the two CMV proteins. We also show that the mature UL40 and Rh67 proteins, which have no previously described function, also contribute to CMV immune evasion by reducing cell surface expression of MHC proteins important for the immune system to detect infected cells. Despite these similarities, our work also reveals possible differences between Rh67 and UL40, and these may have implications for the use of human CMV as the vector for a potential HIV-1 vaccine.

Differential Cell Surface Expression of Rhesus Macaque's Major Histocompatibility Complex Class I Alleles Mamu-B1703 and Mamu-B0101

Diverse peptide presentation of rhesus macaque major histocompatibility complex class I Mamu-A 02 revealed by two peptide complex structures and insights into immune escape of simian immunodeficiency virus.

Construction of Soluble Mamu-b*1703, a Class I Major Histocompatibility Complex of Chinese Rhesus Macaques, Monomer and Tetramer Loaded with a Simian Immunodeficiency Virus Peptide.

Expression and distribution of Chinese rhesus macaque Mamu-B*1703/EGFP in K562 and B16 cells

Identification of Major Histocompatibility Complex Class I Alleles in Chinese Rhesus Macaques

First Glimpse of the Peptide Presentation by Rhesus Macaque MHC Class I: Crystal Structures of Mamu-A*01 Complexed with Two Immunogenic SIV Epitopes and Insights into CTL Escape

Screening of Mamu-A~*01 Gene in Chinese Rhesus Macaques and Detection of Specific CTL Response Targeting the Peptide P11c

Identification of 17 Novel Major Histocompatibility Complex-a Alleles in a Population of Chinese-origin Rhesus Macaques.

Molecular Characterization of Major Histocompatibility Complex Class I Genes from the Giant Panda (ailuropoda Melanoleuca).

Characterization Of The Major Histocompatibility Complex Class Ii Dqb (Mhcmamu-Dqb1) Alleles In A Cohort Of Chinese Rhesus Macaques (Macaca Mulatta)

Frequency of the major histocompatibility complex Mamu-A*01 allele in experimental rhesus macaques in China.

Mamu-A*01 Allele-Mediated Attenuation Of Disease Progression In Simian-Human Immunodeficiency Virus Infection

Molecular characteristics of rhesus macaque interferon-lambda receptor 1 (mmuIFNLR1): Sequence identity, distribution and alteration after simian-human immunodeficiency virus infection in the skin and buccal mucosa

Complex assembly, crystallization and preliminary X-ray crystallographic studies of rhesus macaque MHC Mamu-A*01 complexed with an immunodominant SIV-Gag nonapeptide.

X-ray Crystallographic Characterization of Rhesus Macaque MHC Mamu-A*02 Complexed with an Immunodominant SIV-Gag Nonapeptide.

Immunization with recombinant macaque major histocompatibility complex class I and II and human immunodeficiency virus gp 140 inhibits simian-human immunodeficiency virus infection in macaques

Natural Selection Coupled with Intragenic Recombination Shapes Diversity Patterns in the Major Histocompatibility Complex Class II Genes of the Giant Panda.

Characterization of the Major Histocompatibility Complex Class II DOB, DPB1, and DQB1 Alleles in Cynomolgus Macaques of Vietnamese Origin

Preparation and Identification of Soluble Chinese Rhesus Macaques Mamu-B* 1703 Monomer and Tetramer Loaded with a SIV Peptide

Vectored Gag and Env but Not Tat Show Efficacy Against Simian-Human Immunodeficiency Virus 89.6P Challenge in Mamu-A*01-negative Rhesus Monkeys.

Regulation of the cell surface expression of classical and non-classical MHC proteins by the human cytomegalovirus UL40 and rhesus cytomegalovirus Rh67 proteins

Differential Cell Surface Expression of Rhesus Macaque's Major Histocompatibility Complex Class I Alleles Mamu-B*1703 and Mamu-B*0101